Yankees Score with ...
Health Care: Drugs
Horizon Pharma Inc (HZNP: NASDAQ)
$2.40 0.01 | 0.42%
05/24/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 104.09M | 17.97M | 5.38M | 7.16M |
| Receivables | 3.46M | 2.37M | 575.00K | 0.00 |
| Inventories | 5.24M | 1.20M | 306.00K | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 116.92M | 25.05M | 7.37M | 7.35M |
| Property, Plant & Equipment, Gross | 5.23M | 4.02M | 2.42M | 841.00K |
| Accumulated Depreciation & Depletion | 1.51M | 771.00K | 315.00K | 94.00K |
| Property, Plant & Equipment, Net | 3.72M | 3.24M | 2.11M | 747.00K |
| Intangibles | 68.89M | 72.24M | 39.99M | 0.00 |
| Other Non-Current Assets | 4.45M | 547.00K | 112.22M | 114.00K |
| Total Non-Current Assets | 77.07M | 76.03M | 154.32M | 861.00K |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 193.98M | 101.08M | 161.68M | 8.21M |
| Accounts Payable | 5.99M | 8.17M | 2.51M | 1.76M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 52.00K | 196.00K | 0.00 | 0.00 |
| Total Current Liabilities | 36.94M | 23.98M | 25.31M | 8.26M |
| Long Term Debt | 36.87M | 15.83M | 14.52M | 3.13M |
| Deferred Income Taxes | 4.41M | 9.56M | 24.80M | 0.00 |
| Other Non-Current Liabilities | 9.80M | 5.79M | 1.00K | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 51.07M | 31.18M | 39.32M | 3.13M |
| Total Liabilities | 88.01M | 55.17M | 64.63M | 11.39M |
| Preferred Stock Equity | 0.00 | 0.00 | 2.00K | 1.00K |
| Common Stock Equity | 105.98M | 45.91M | 97.05M | -3.18M |
| Common Par | 6.00K | 2.00K | 0.00 | 0.00 |
| Additional Paid In Capital | 417.46M | 270.02M | 206.34M | 76.81M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -308.11M | -220.32M | -107.05M | -79.99M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -3.37M | -3.79M | -2.23M | 0.00 |
| Total Capitalization | 142.84M | 61.75M | 111.57M | -44.00K |
| Total Equity | 105.98M | 45.91M | 97.06M | -3.18M |
| Total Liabilities & Stock Equity | 193.98M | 101.08M | 161.68M | 8.21M |
| Total Common Shares Outstanding | 61.72M | 19.63M | 19.15M | 19.15M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 38.87M | 9.01M | 0.00 | 0.00 |
| Diluted Weighted Shares Outstanding | 38.87M | 9.01M | 0.00 | 0.00 |
| Number of Employees | 247 | 164 | 39 | NA |
| Number of Part-Time Employees | 0 | 0 | 0 | NA |
Portfolios with HZNP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorDrugs Facing FDA Approval i...
- Usersuziltd
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Facing FDA Ap...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
Latest HZNP Headlines from TheStreet
- 3 Stocks Under $10 Making Big Moves 03.15.13 | 07:03 am
- January Effect Stock Picks Here Are 7 Possible Winners For 2013 12.28.12 | 03:12 pm
- Shorting Alexza Pharma On FDA's Adasuve Approval 12.19.12 | 07:12 am
- 11 Stocks With Significant Institutional And Insider Buying 12.18.12 | 06:12 pm
- 10 Stocks With Bullish Institutional And Insider Buying Activities 12.04.12 | 04:12 pm
- 5 Stocks Insiders Love Right Now 10.03.12 | 01:10 pm
- Horizon Pharma's CEO Discusses Q2 2012 Results - Earnings Call Transcript 08.10.12 | 02:08 pm
- Biotech Stock Mailbag: Amarin, Sarepta 07.27.12 | 06:07 am
- Horizon Pharma: Rayos FDA Approval Thursday Seems Likely 07.25.12 | 10:07 am
- 28 Drugs Facing FDA Approval in 2012-2013 07.24.12 | 07:07 am
Press Releases for HZNP
- Horizon Pharma Announces Completion Of Sales Force Expansion - PR Newswire 10.01.12 | 07:10 am
- Horizon Pharma Announces Receipt Of Two Additional U.S. Patent Allowances For DUEXIS® - PR Newswire 09.28.12 | 07:09 am
- Horizon Pharma Announces FDA Approval Of RAYOS® (prednisone) Delayed-Release Tablets For Rheumatoid Arthritis And Multiple Additional Indications - PR Newswire 07.26.12 | 04:07 pm
- The Grünenthal Group Enters Into Exclusive Agreement With Horizon Pharma For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 08:06 am
- Horizon Pharma Enters Into Exclusive Agreement With Grunenthal For Commercialization Of DUEXIS® In Latin America - PR Newswire 06.19.12 | 07:06 am
- Horizon Pharma And Mallinckrodt, The Pharmaceuticals Business Of Covidien, Enter Into Co-Promotion Agreement For DUEXIS® In The United States - PR Newswire 06.18.12 | 06:06 am
- Horizon Pharma Announces Issuance Of U.S. Patent Covering RAYOS (delayed-release Prednisone) - PR Newswire 05.29.12 | 07:05 am
Partner Headlines for HZNP
- Pre-Market Earnings Report for March 18, 2013 : KIOR, IMOS, NMRX, TA, HWCC, INSM, AMRC, PTX, STRL, HZNP, UTSI, DEXO - NASDAQ 03.15.13 | 08:03 pm
- The January Effect And 3 Biopharma Stocks - Seeking Alpha 11.09.12 | 09:11 am
- From Earlier: Horizon Pharma Announces US Patent for Rayos Tablet - Benzinga 10.15.12 | 09:10 am
- Huge Insider Buy Makes This $3.50 Biopharma Stock An Intriguing Speculative Play - Seeking Alpha 10.07.12 | 08:10 am
- Morning Market Losers - Benzinga 09.20.12 | 01:09 pm
- A Pullback Would Be Healthy For Repros Therapeutics - Seeking Alpha 09.20.12 | 09:09 am
- 5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year - Seeking Alpha 08.28.12 | 09:08 am
- 6 Healthcare Stocks With Pending August Catalysts - Seeking Alpha 08.01.12 | 09:08 am
- 4 Hot Healthcare Stocks Making Mid-Week Noise - Seeking Alpha 07.25.12 | 09:07 am
- Earnings Preview: Covidien - Analyst Blog - Zacks 07.23.12 | 10:07 am
